Request Deal Involvement

Omega Funds led a $120m Series B round in Ikena Oncology.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Jefferies & Company

financial advisors

Jefferies & Company

Argot Partners

pr advisors

Argot Partners

or

Principals

IKENA ONCOLOGY

target

IKENA ONCOLOGY

OMEGA FUNDS

bidder

OMEGA FUNDS

FIDELITY MANAGEMENT & RESEARCH COMPANY

bidder

FIDELITY MANAGEMENT & RESEARCH COMPANY

SURVEYOR CAPITAL

bidder

SURVEYOR CAPITAL

THE INVUS GROUP LLC

bidder

THE INVUS GROUP LLC

FARALLON CAPITAL MANAGEMENT LLC

bidder

FARALLON CAPITAL MANAGEMENT LLC

BVF PARTNERS

bidder

BVF PARTNERS

BLUE OWL HEALTHCARE OPPORTUNITIES (EX-COWEN HEALTHCARE INVESTMENTS)

bidder

BLUE OWL HEALTHCARE OPPORTUNITIES (EX-COWEN HEALTHCARE INVESTMENTS)

LOGOS CAPITAL

bidder

LOGOS CAPITAL

HEALTHCOR PARTNERS MANAGEMENT

bidder

HEALTHCOR PARTNERS MANAGEMENT

ATLAS VENTURE LP

bidder

ATLAS VENTURE LP

ORBIMED PE

bidder

ORBIMED PE

BRISTOL MYERS SQUIBB COMPANY

bidder

BRISTOL MYERS SQUIBB COMPANY

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite